The task combines optimal technology with the best scientific expertise to build up new medical therapies. The overall project will concentrate on three areas where European countries is in a relatively favourable position compared with the united states – human tissue resources, ribonucleic acid technology, and structural proteomics. However, the initial concentrate will be on the advancement of genomics targets in hepatocellular carcinoma or liver cancer as it is one of the leading causes of cancer death world-wide and has a inadequate prognosis.But most prostate cancers become resistant to these remedies and resume growing ultimately. Abiraterone acetate is made to deal with these tumors by inhibiting the production of androgen in the testes, the adrenal prostate and glands cancer tumors themselves. The Phase-III trial included 1195 patients from 13 countries whose metastatic, castration-resistant prostate cancer had previously been treated with one of two chemotherapeutic brokers that included docetaxel. Among the 398 individuals randomly assigned to get the corticosteroid prednisone plus placebo, median overall survival was 10.9 months.